WTA
ANGO icon

Washington Trust Advisors’s AngioDynamics ANGO Stock Holding History

Washington Trust Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.3K Buy
3,900
+1,500
+63% +$16.3K ﹤0.01% 366
2025
Q4 		$30.8K Hold
2,400
– – ﹤0.01% 394
2025
Q3 		$26.8K Buy
+2,400
New +$23.2K ﹤0.01% 410

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Washington Trust Advisors's ANGO Position: Q1 2026 in Review

Washington Trust Advisors increased its AngioDynamics (ANGO) stake by 63% in Q1 2026, buying an estimated $16.3K and bringing the position to 3,900 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

Washington Trust Advisors first reported a position in ANGO in Q3 2025 and has held it in 3 quarters since. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Washington Trust Advisors held 3,900 shares of AngioDynamics worth $44.3K as of Q1 2026.
  • Washington Trust Advisors bought 1,500 AngioDynamics shares in Q1 2026, an estimated $16.3K.
  • AngioDynamics made up ﹤0.01% of Washington Trust Advisors's portfolio in Q1 2026, its #366 holding.
  • Washington Trust Advisors first reported a position in AngioDynamics in Q3 2025 and has held it in 3 quarters since.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Washington Trust Advisors's 13F filing for Q1 2026, filed 6 Apr 2026.